Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial by Nadel, Simon, FRCP, Goldstein, Brahm, MD, Williams, Mark D, MD, Dalton, Heidi, MD, Peters, Mark, PhD, Macias, William L, MD, Abd-Allah, Shamel A, MD, Levy, Howard, FRCP, Angle, Robinette, RN, Wang, Dazhe, PhD, Sundin, David P, PhD, Giroir, Brett, Dr

Get full text